Pulmonary embolism

Pulmonary embolism (PE) is the third leading cardiovascular cause of death after heart attacks and stroke. PE is caused by blood clots in the pulmonary arteries. These are often caused by clots from the venous system, including thrombus from trauma, surgery or deep vein thrombosis (DVT). Treatment has traditionally been systemic use of thrombolytic drugs to dissolve the clot. But in cases there is a massive, life-threatening PE, or chronic clot burden that have remained in a vessel for an extended period of time, mechanical thrombectomy and ultrasound-assisted catheter-directed thrombolysis (USCDT) is being used as more targeted and aggressive treatments.

RSS icon
Thumbnail

Catheter-directed therapy treatments for pulmonary embolism on the rise

Catheter-directed therapy (CDT) is being used to treat pulmonary embolism (PE) more and more by healthcare providers, according to new research published in the Journal of Vascular and Interventional Radiology.

Thumbnail

AI solution for pulmonary embolism workflow receives CE certification

Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced that its AI-based solution for improving pulmonary embolism (PE) workflow has received CE certification.

Aidoc announces CE mark for the first AI-based workflow tool for Pulmonary Embolism

Aidoc’s solution for flagging and prioritizing pulmonary embolisms is now commercially available in Europe

Example of spectral, or dual-energy CT, confirming a pulmonary embolism (PE). Image courtesy of Philips Healthcare

Dual-energy CTA iodine maps offer small benefit in diagnosing pulmonary embolism

Dual-energy (DE) CT iodine maps offer a slight benefit when paired with traditional CT angiography images in diagnosing pulmonary embolism (PE), reported researchers in a Sept. 11 Radiology study.

Thumbnail

IVC filters improve in-hospital mortality rates for patients with congestive heart failure, pulmonary embolism

Inferior vena cava (IVC) filter placement is associated with improved in-hospital mortality rates for patients admitted with congestive heart failure (CHF) and pulmonary embolism (PE), according to a new study published by the American Journal of Roentgenology.

Thumbnail

FDA clears pulmonary embolism thrombectomy device

The FlowTriever System has become the first thrombectomy device designed to treat pulmonary embolism (PE) to be cleared by the FDA, Inari Medical announced in a May 21 press release.

Example of spectral, or dual-energy CT, confirming a pulmonary embolism (PE). Image courtesy of Philips Healthcare

MRA vs CTA for evaluating pulmonary embolism: Does the chosen modality impact downstream imaging utilization?

MR angiography (MRA) is a relatively new alternative to CT angiography (CTA) for the evaluation of suspected pulmonary embolism (PE) and it even has one major advantage over CTA: it does not expose patients to ionizing radiation.

Thumbnail

Novel device treats pulmonary embolism without clot-dissolving drugs

A new device allows clinicians to remove blood clots from the pulmonary arteries and improve right ventricular function without the use of thrombolytics, according to a late-breaking clinical study presented April 26 at SCAI 2018 in San Diego.

Displaying 25 - 32 of 36
Design by Adaptive Theme